Multiple Sclerosis Clinical Trial
Official title:
Effect of Need to Void on Rectal Sensory Function in Multiple Sclerosis, a Manometric Study
Multiple sclerosis causes demyelinating lesions, which can induce multiple symptoms.
Ano-rectal avec urinary disorders are frequent due to specific lesions in inhibitor/activator
encephalic centers, or interruption on medullary conduction. It seems to be evident that
anorectal and urinary disorders are link, because of similar anatomic ways and control
process.
To our knowledge several studies test the effect of rectal distension and bladder sensory
function but only one study examined the effect of bladder filling on rectal sensitivity on
healthy people. The effect of bladder filling on rectal sensory function in patient with
neurological disease stay unknown, while dysfunction often occur concomitant, and therapeutic
actions in one organ may influence function of the other.
Anorectal manometry is the gold standard for the evaluation of rectal sensory function and
the volume of constant sensation to need to defecate is reported in literature as the most
reproducible measure.
Primary aim is to assess the effect of need to void on volume of constant sensation to need
to defecate in multiple sclerosis with anorectal symptoms. Secondary aim is to identify the
effect of need to void on modulation of rectoanal inhibitory reflex (RAIR) and external anal
sphincter resting pressure.
Patient with multiple sclerosis over 18 years old, consulting for anorectal disorders in a
tertiary center, with an indication to realize an anorectal manometry are included.
History and treatment, height, weight, Expanded Disability Status Scale (EDSS), anorectal and
urinary symptoms severity by Bristol, Neurogenic Bowel Dysfunction (NBD), Cleveland, Kess,
Urinary Symptom Score (USP) scores, and last urodynamic data are recorded. Patient are asked
to drink water until they feel a strong need to void, for which they would go to urinate at
home. 3 void volume with portable sonography are done, and the higher is recorded.
Anorectal manometries are realized by the same doctor, in a specific place, with calm. Before
the manometric examination, thermal and vibratory sensory thresholds on the right hand are
collected. The patient is then placed in a left lateral position. Then the anorectal
manometry's catheter is inserted and collect of the external anal sphincter resting pressure
begins. Then the investigator proceed to search for RAIR by 5 brief distensions of the
intrarectal balloon with increasing volumes of 10 mL from 10 mL to 50 mL. Finally, the
investigator collect the threshold volumes of perception, need and maximum tolerable by
gradually distending the intra-rectal balloon to 5 mL/s from 0 mL to 300 mL. Toilets are just
next to the table of examination.
Next, patient can urinate. 3 post void residual volume with portable sonography are done, and
the higher is recorded.
The same tests are realized after urinate, in the same order. After the classical complete
manometry was performed.
Primary outcome is the volume of constant sensation to need to defecate Secondary outcomes
are the modulation of RAIR and the external anal sphincter resting pressure. Manometric data
are collected.
Influence of age, EDSS, severity of symptoms, manometric data and detrusor overactivity on
rectal sensory function will be study in secondary analysis.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |